Evidence for Cross-Protection Against Subsequent Febrile Respiratory Illness Episodes From Prior Infections by Different Viruses Among Singapore Military Recruits 2009–2014

Author:

Chen I-Cheng Mark12ORCID,Loh Jin Phang3,Chuah Cheryl X P1,Gao Qiu Han Christine4,Sun Yinxiaohe15,Ng Sock Hoon3,Koh Wee-Hong Victor3,Goh Ee Hui1,Zhao Xiahong1,Tambyah Paul Anantharajah6,Cook Alex R1,Chng Jeremiah4,Pang Junxiong15,Tan Boon-Huan37,Lee Vernon J14

Affiliation:

1. Saw Swee Hock School of Public Health, National University of Singapore and National University Hospital System, Singapore

2. Infectious Disease Research and Training Office, National Centre for Infectious Diseases, Singapore

3. DSO National Laboratories, Singapore

4. Biodefence Centre, Headquarters Medical Corps, Singapore Armed Forces, Singapore

5. Centre for Infectious Disease Epidemiology and Research, Saw Swee Hock School of Public Health, National University of Singapore and National University Hospital System, Singapore

6. Yong Loo Lin School of Medicine, National University of Singapore and National University Hospital System, Singapore

7. Infection and Immunity, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

Abstract

Abstract Background Few studies have evaluated the relative cross-protection conferred by infection with different groups of viruses through studies of sequential infections in humans. We investigated the presence of short-lived relative cross-protection conferred by specific prior viral infections against subsequent febrile respiratory illness (FRI). Methods Men enlisted in basic military training between December 2009 and December 2014 were recruited, with the first FRI as the study entry point. ResPlex II assays and real-time polymerase chain reaction assays were used to detect viral pathogens in nasal wash samples, and survival analyses were performed to determine whether infection with particular viruses conferred short-lived relative cross-protection against FRI. Results Prior infection with adenovirus (hazard ratio [HR], 0.24; 95% confidence interval [CI], .14–.44) or influenza virus (HR, 0.52; 95% CI, .38–.73) conferred relative protection against subsequent FRI episode. Results were statistically significant even after adjustment for the interval between enlistment and FRI (P < .001). Adenovirus-positive participants with FRI episodes tended to be protected against subsequent infection with adenovirus, coronavirus, enterovirus/rhinovirus, and influenza virus (P = .062–.093), while men with influenza virus–positive FRI episodes tended be protected against subsequent infection with adenovirus (P = .044) and influenza virus (P = .081). Conclusion Prior adenovirus or influenza virus infection conferred cross-protection against subsequent FRI episodes relative to prior infection due to other circulating viruses.

Funder

Ministry of Education - Singapore

Centre for Infectious Disease Epidemiology and Research

Saw Swee Hock School of Public Health

Singapore Ministry of Defence

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference28 articles.

1. Mosaic diseases in the Canary Islands, West Africa and Gibraltar;McKinney;J Agric Res,1929

2. Interference phenomena between animal viruses; a review;Henle;J Immunol,1950

3. Classics in oncology: virus interference: I. the interferon;Isaacs;CA Cancer J Clin,1988

4. Investigating viral interference between influenza a virus and human respiratory syncytial virus in a ferret model of infection;Chan;J Infect Dis,2018

5. Virus interference between H7N2 low pathogenic avian influenza virus and lentogenic Newcastle disease virus in experimental co-infections in chickens and turkeys;Costa-Hurtado;Vet Res,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3